PROSPER
Frontier Medicines Corporation
Frontier Medicines Corporation
Filamon LTD
Bristol-Myers Squibb
PMV Pharmaceuticals, Inc
Mayo Clinic
Verastem, Inc.
M.D. Anderson Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
A2 Biotherapeutics Inc.
Essen Biotech
Auricula Biosciences Inc.
3H Pharmaceuticals Co., Ltd.
M.D. Anderson Cancer Center
Second Life Therapeutics
Eli Lilly and Company
VM Oncology, LLC
Takeda
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
NantCell, Inc.
Revolution Medicines, Inc.
Eli Lilly and Company
LigaChem Biosciences, Inc.
Shanghai Escugen Biotechnology Co., Ltd
A2 Biotherapeutics Inc.
Incyte Corporation
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Cancer Research UK
Cancer Research UK
Hoffmann-La Roche
Gustave Roussy, Cancer Campus, Grand Paris
Intensity Therapeutics, Inc.
Evopoint Biosciences Inc.
NextCure, Inc.
Coherent Biopharma (Hefei) Co., Ltd.
Chongqing Precision Biotech Co., Ltd
NantCell, Inc.
Second Affiliated Hospital of Guangzhou Medical University
NextCure, Inc.
Mural Oncology, Inc
Fusion Pharmaceuticals Inc.
Klus Pharma Inc.
Kineta Inc.
Revolution Medicines, Inc.
National Institutes of Health Clinical Center (CC)
Chongqing Precision Biotech Co., Ltd
Kiadis Pharma
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Seagen Inc.